Zuellig Pharma and Organon Partner for Women's Health in Myanmar
This partnership is crucial for improving reproductive health outcomes in Myanmar, a region where access to such services can be limited.
Strategic partnership with Organon to expand women's health solutions access in Myanmar.
Zuellig Pharma and Organon have formed a strategic partnership to expand access to women's health solutions in Myanmar. The collaboration focuses on addressing unintended pregnancies and improving reproductive health through enhanced distribution and educational initiatives, aiming to make essential products and information more readily available to women across the country.
This partnership is crucial for improving reproductive health outcomes in Myanmar, a region where access to such services can be limited. By combining Organon's product portfolio with Zuellig Pharma's distribution network and local market understanding, the initiative aims to empower women with better choices and healthcare, contributing to overall public health improvements.
This initiative directly addresses critical women's health needs in Myanmar, a Southeast Asian nation, by improving access to reproductive health products and education.
Where this signal fits in the broader landscape.
Zuellig Pharma Acquires Zam-Buk and Vapex Brands from Bayer
Zuellig Pharma Expands Lundbeck Partnership for Neuro-Psychiatric Solutions
Zuellig Pharma Opens Clinical Trial Support Innovation Center in South Korea
Zuellig Pharma Opens Clinical Trial Support Center in South Korea
Zuellig Pharma Launches Lilly's Obesity and Diabetes Medicine in Thailand
https://www.zuelligpharma.com/news-insights/zuellig-pharma-and-organon-partner-to-expand-access-to-womens-health-solutions-in-myanmar
Read Full SourceGet curated intelligence delivered to your inbox. No spam, unsubscribe anytime.
Sign in to save notes on signals.
로그인